A76109
3-氨基-1-丙磺酸
97%
别名:
3-氨基丙烷磺酸, 3APS, 高牛磺酸
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
线性分子式:
H2N(CH2)3SO3H
化学文摘社编号:
分子量:
139.17
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352100
EC Number:
222-977-4
MDL number:
Assay:
97%
Form:
solid
Quality Level
assay
97%
form
solid
mp
293 °C (dec.) (lit.)
SMILES string
NCCCS(O)(=O)=O
InChI
1S/C3H9NO3S/c4-2-1-3-8(5,6)7/h1-4H2,(H,5,6,7)
InChI key
SNKZJIOFVMKAOJ-UHFFFAOYSA-N
Application
重要的 GABA-mimetic 药物成分，可引起类似于 γ-氨基丁酸 (GABA) 诱导的神经反应。
存储类别
13 - Non Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
D Saumier et al.
The journal of nutrition, health & aging, 13(9), 808-812 (2009-10-09)
Tramiprosate (homotaurine, ALZHEMEDTM) was recently investigated for its efficacy, safety and disease-modification effects in a Phase III clinical study in mild to moderate Alzheimer's disease (AD) patients (the Alphase study). The primary cognitive endpoint measure of that study was the
R Nageswara Rao et al.
Journal of pharmaceutical and biomedical analysis, 55(2), 282-287 (2011-02-18)
Alzheimer disease (AD) is characterized pathologically by extracellular amyloid deposits composed of amyloid β (Aβ) protein. A simple and rapid method using HPLC with fluorescence detector was developed and validated for determination of tramiprosate in rat plasma. Pre-column derivatization of
S Gauthier et al.
The journal of nutrition, health & aging, 13(6), 550-557 (2009-06-19)
The efficacy, safety and disease-modification of tramiprosate (homotaurine)were investigated in a recently completed large-scale Phase III clinical study in patients with mild to moderate Alzheimer's disease (AD), the Alphase study. Disease-modification was assessed using longitudinal volumetric MRI (vMRI) measurements of
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| A76109-5G | 04061832421223 |
| A76109-1G | 04061825899466 |